Somatic mutations of activating signalling, transcription factor, and tumour suppressor are a precondition for leukaemia transformation in myelodysplastic syndromes
F Xu, LY Wu, J Guo, Q He, Z Zhang… - Journal of Cellular and …, 2022 - Wiley Online Library
The transformation biology of secondary acute myeloid leukaemia (AML) from
myelodysplastic syndromes (MDSs) is still not fully understood. We performed paired self …
myelodysplastic syndromes (MDSs) is still not fully understood. We performed paired self …
[HTML][HTML] Somatic mutations of activating signalling, transcription factor, and tumour suppressor are a precondition for leukaemia transformation in myelodysplastic …
F Xu, LY Wu, J Guo, Q He, Z Zhang… - Journal of Cellular and …, 2022 - ncbi.nlm.nih.gov
The transformation biology of secondary acute myeloid leukaemia (AML) from
myelodysplastic syndromes (MDSs) is still not fully understood. We performed paired self …
myelodysplastic syndromes (MDSs) is still not fully understood. We performed paired self …
Somatic mutations of activating signalling, transcription factor, and tumour suppressor are a precondition for leukaemia transformation in myelodysplastic syndromes.
F Xu, LY Wu, J Guo, Q He, Z Zhang… - Journal of Cellular and …, 2022 - europepmc.org
The transformation biology of secondary acute myeloid leukaemia (AML) from
myelodysplastic syndromes (MDSs) is still not fully understood. We performed paired self …
myelodysplastic syndromes (MDSs) is still not fully understood. We performed paired self …
Somatic mutations of activating signalling, transcription factor, and tumour suppressor are a precondition for leukaemia transformation in myelodysplastic syndromes
F Xu, LY Wu, J Guo, Q He, Z Zhang… - Journal of Cellular and …, 2022 - search.proquest.com
The transformation biology of secondary acute myeloid leukaemia (AML) from
myelodysplastic syndromes (MDSs) is still not fully understood. We performed paired self …
myelodysplastic syndromes (MDSs) is still not fully understood. We performed paired self …
Somatic mutations of activating signalling, transcription factor, and tumour suppressor are a precondition for leukaemia transformation in myelodysplastic syndromes
F Xu, LY Wu, J Guo, Q He… - Journal of cellular and …, 2022 - pubmed.ncbi.nlm.nih.gov
The transformation biology of secondary acute myeloid leukaemia (AML) from
myelodysplastic syndromes (MDSs) is still not fully understood. We performed paired self …
myelodysplastic syndromes (MDSs) is still not fully understood. We performed paired self …
Somatic mutations of activating signalling, transcription factor, and tumour suppressor are a precondition for leukaemia transformation in myelodysplastic syndromes.
F Xu, LY Wu, J Guo, Q He, Z Zhang… - Journal of Cellular and …, 2022 - europepmc.org
The transformation biology of secondary acute myeloid leukaemia (AML) from
myelodysplastic syndromes (MDSs) is still not fully understood. We performed paired self …
myelodysplastic syndromes (MDSs) is still not fully understood. We performed paired self …